These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 25034491)
1. Mechanisms of hepatitis B virus resistance development. Warner N; Locarnini S Intervirology; 2014; 57(3-4):218-24. PubMed ID: 25034491 [TBL] [Abstract][Full Text] [Related]
2. Antiviral effect of entecavir in chronic hepatitis B: influence of prior exposure to nucleos(t)ide analogues. Reijnders JG; Deterding K; Petersen J; Zoulim F; Santantonio T; Buti M; van Bömmel F; Hansen BE; Wedemeyer H; Janssen HL; J Hepatol; 2010 Apr; 52(4):493-500. PubMed ID: 20185191 [TBL] [Abstract][Full Text] [Related]
3. Prevalence and types of drug-resistant variants in Chinese patients with acute hepatitis B. Su F; Dai J; Yang S; Jiang X; Cui X; Ning H; Li J; Huang M J Med Virol; 2015 Sep; 87(9):1527-31. PubMed ID: 26032700 [TBL] [Abstract][Full Text] [Related]
4. Evolution of full-length HBV sequences in chronic hepatitis B patients with sequential lamivudine and adefovir dipivoxil resistance. Chen CH; Lee CM; Tung WC; Wang JH; Hung CH; Hu TH; Wang JC; Lu SN; Changchien CS J Hepatol; 2010 Apr; 52(4):478-85. PubMed ID: 20185198 [TBL] [Abstract][Full Text] [Related]
5. Profile of HBV antiviral resistance mutations with distinct evolutionary pathways against nucleoside/nucleotide analogue treatment among Chinese chronic hepatitis B patients. Yang JX; Liu BM; Li XG; Yan CH; Xu J; Sun XW; Wang YH; Jiao XJ; Yan L; Dong JP; Hou CS; Abuduheilili X; Li T; Zhuang H Antivir Ther; 2010; 15(8):1171-8. PubMed ID: 21149924 [TBL] [Abstract][Full Text] [Related]
6. Similar evolution of hepatitis B virus quasispecies in patients with incomplete adefovir response receiving tenofovir/emtricitabine combination or tenofovir monotherapy. Lavocat F; Dény P; Pichoud C; Al Hawajri N; Kitrinos K; Borroto-Esoda K; Zoulim F J Hepatol; 2013 Oct; 59(4):684-95. PubMed ID: 23742912 [TBL] [Abstract][Full Text] [Related]
7. Comparison of Detection Rate and Mutational Pattern of Drug-Resistant Mutations Between a Large Cohort of Genotype B and Genotype C Hepatitis B Virus-Infected Patients in North China. Li X; Liu Y; Xin S; Ji D; You S; Hu J; Zhao J; Wu J; Liao H; Zhang XX; Xu D Microb Drug Resist; 2017 Jun; 23(4):516-522. PubMed ID: 27792585 [TBL] [Abstract][Full Text] [Related]
8. Hepatitis B virus drug resistance tools: one sequence, two predictions. Neumann-Fraune M; Beggel B; Kaiser R; Obermeier M Intervirology; 2014; 57(3-4):232-6. PubMed ID: 25034493 [TBL] [Abstract][Full Text] [Related]
9. Snapshot on drug-resistance rate and profiles in patients with chronic hepatitis B receiving nucleos(t)ide analogues in clinical practice. Salpini R; Alteri C; Cento V; Pollicita M; Micheli V; Gubertini G; De Sanctis GM; Visca M; Romano S; Sarrecchia C; Andreoni M; Angelico M; Parruti G; Svicher V; Perno CF J Med Virol; 2013 Jun; 85(6):996-1004. PubMed ID: 23588725 [TBL] [Abstract][Full Text] [Related]
10. Variant of hepatitis B virus with primary resistance to adefovir. Schildgen O; Sirma H; Funk A; Olotu C; Wend UC; Hartmann H; Helm M; Rockstroh JK; Willems WR; Will H; Gerlich WH N Engl J Med; 2006 Apr; 354(17):1807-12. PubMed ID: 16641397 [TBL] [Abstract][Full Text] [Related]
11. Variability of reverse transcriptase and overlapping S gene in hepatitis B virus isolates from untreated and lamivudine-resistant chronic hepatitis B patients. Pollicino T; Isgrò G; Di Stefano R; Ferraro D; Maimone S; Brancatelli S; Squadrito G; Di Marco V; Craxì A; Raimondo G Antivir Ther; 2009; 14(5):649-54. PubMed ID: 19704167 [TBL] [Abstract][Full Text] [Related]
12. [The efficacy of nucleoside/nucleotide analogue on chronic hepatitis B]. Lin Q; Zhang DZ Zhonghua Gan Zang Bing Za Zhi; 2009 Oct; 17(10):722-5. PubMed ID: 19874684 [No Abstract] [Full Text] [Related]
13. Substitution at rt269 in Hepatitis B Virus Polymerase Is a Compensatory Mutation Associated with Multi-Drug Resistance. Ahn SH; Kim DH; Lee AR; Kim BK; Park YK; Park ES; Ahn SH; Shin GC; Park S; Kang HS; Rhee JK; Yang SI; Chong Y; Kim KH PLoS One; 2015; 10(8):e0136728. PubMed ID: 26322642 [TBL] [Abstract][Full Text] [Related]
14. High frequency of complex mutational patterns in lamivudine resistant hepatitis B virus isolates. Neumann-Fraune M; Beggel B; Pfister H; Kaiser R; Verheyen J J Med Virol; 2013 May; 85(5):775-9. PubMed ID: 23408582 [TBL] [Abstract][Full Text] [Related]
15. [Resistance in hepatitis B virus]. Sheldon J; Sarmento E Castro R; Soriano V Enferm Infecc Microbiol Clin; 2008 May; 26 Suppl 7():49-55. PubMed ID: 19100231 [TBL] [Abstract][Full Text] [Related]
16. Viral genotype and baseline load predict the response to adefovir treatment in lamivudine-resistant chronic hepatitis B patients. Buti M; Elefsiniotis I; Jardi R; Vargas V; Rodriguez-Frias F; Schapper M; Bonovas S; Esteban R J Hepatol; 2007 Sep; 47(3):366-72. PubMed ID: 17561304 [TBL] [Abstract][Full Text] [Related]
17. Randomized comparison of tenofovir disoproxil fumarate vs emtricitabine and tenofovir disoproxil fumarate in patients with lamivudine-resistant chronic hepatitis B. Fung S; Kwan P; Fabri M; Horban A; Pelemis M; Hann HW; Gurel S; Caruntu FA; Flaherty JF; Massetto B; Dinh P; Corsa A; Subramanian GM; McHutchison JG; Husa P; Gane E Gastroenterology; 2014 Apr; 146(4):980-8. PubMed ID: 24368224 [TBL] [Abstract][Full Text] [Related]
18. Redetection of HBV lamivudine-resistant mutations in a patient under entecavir therapy, who had been treated sequentially with nucleos(t)ide analogues. Rodriguez-Frias F; Jardi R; Schaper M; Gimferrer M; Elefsiniotis I; Tabernero D; Esteban R; Buti M J Med Virol; 2007 Nov; 79(11):1671-3. PubMed ID: 17854030 [TBL] [Abstract][Full Text] [Related]
19. Restored function of HBV-specific T cells after long-term effective therapy with nucleos(t)ide analogues. Boni C; Laccabue D; Lampertico P; Giuberti T; Viganò M; Schivazappa S; Alfieri A; Pesci M; Gaeta GB; Brancaccio G; Colombo M; Missale G; Ferrari C Gastroenterology; 2012 Oct; 143(4):963-73.e9. PubMed ID: 22796241 [TBL] [Abstract][Full Text] [Related]
20. Evolution of hepatitis B virus mutation during entecavir rescue therapy in patients with antiviral resistance to lamivudine and adefovir. Choe WH; Hong SP; Kim BK; Ko SY; Jung YK; Kim JH; Yeon JE; Byun KS; Kim KH; Ji SI; Kim SO; Lee CH; Kwon SY Antivir Ther; 2009; 14(7):985-93. PubMed ID: 19918102 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]